| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2775148 | Experimental and Molecular Pathology | 2014 | 7 Pages |
Abstract
MicroRNA-34 is involved in pathogenesis in cancer by targeting different tumor-related genes. It could be a biomarker for predicting the prognosis of patients with cancer. In addition, miR-34 is involved in the tumor angiogenesis. Understanding the mechanism of the miR-34 in cancer and tumor angiogenesis will open horizons for development of anti-cancer and anti-angiogenesis drugs.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Hamidreza Maroof, Ali Salajegheh, Robert Anthony Smith, Alfred King-Yin Lam,